Abbott Laboratories
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B |
| Established Pharmaceutical Products | $5.54B | $5.19B | $5.07B | $4.91B | $4.72B | $4.30B | $4.49B | $4.42B |
| Nutritional Products | $8.45B | $8.41B | $8.15B | $7.46B | $8.29B | $7.65B | $7.41B | $7.23B |
| Diagnostic Products | $8.94B | $9.34B | $9.99B | $16.58B | $15.64B | $10.81B | $7.71B | $7.50B |
| Vascular Products | — | — | — | — | — | — | — | — |
| Medical Devices | $21.39B | $18.99B | $16.89B | $14.69B | $14.37B | $11.79B | $12.24B | $11.37B |
| Other | $17.0M | $16.0M | $14.0M | $11.0M | $52.0M | $66.0M | $57.0M | $62.0M |
| Cost of Revenue | $19.32B | $18.71B | $17.98B | $19.14B | $18.54B | $15.00B | $13.23B | $12.71B |
| Gross Profit | $25.01B | $23.24B | $22.13B | $24.51B | $24.54B | $19.61B | $18.67B | $17.87B |
| Gross Margin | 56.4% | 55.4% | 55.2% | 56.1% | 57.0% | 56.6% | 58.5% | 58.4% |
| Operating Expenses | ||||||||
| Research & Development | $2.94B | $2.84B | $2.74B | $2.89B | $2.74B | $2.42B | $2.44B | $2.30B |
| SG&A Expense | $12.33B | $11.70B | $10.95B | $11.25B | $11.32B | $9.70B | $9.77B | $9.74B |
| Operating Income | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B |
| Operating Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% |
| Interest Expense | — | — | $637.0M | $558.0M | $533.0M | $546.0M | $670.0M | $826.0M |
| Pretax Income | $8.47B | $7.01B | $6.66B | $8.31B | $8.21B | $4.97B | $4.08B | $2.87B |
| Income Tax Expense | $1.94B | $-6.39B | $941.0M | $1.37B | $1.14B | $497.0M | $390.0M | $539.0M |
| Net Income | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B |
| Net Margin | 14.7% | 31.9% | 14.3% | 15.9% | 16.4% | 13.0% | 11.6% | 7.7% |
| EPS (Basic) | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 | $2.52 | $2.07 | $1.34 |
| EPS (Diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 |
| Shares Outstanding (Basic) | 1.74B | 1.74B | 1.74B | 1.75B | 1.78B | 1.77B | 1.77B | 1.76B |
| Shares Outstanding (Diluted) | 1.75B | 1.75B | 1.75B | 1.76B | 1.79B | 1.79B | 1.78B | 1.77B |
| Dividends Per Share | $2.40 | $2.24 | $2.08 | $1.92 | — | — | — | — |